These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 21384167)

  • 1. The effect of various vitamin D supplementation regimens in breast cancer patients.
    Peppone LJ; Huston AJ; Reid ME; Rosier RN; Zakharia Y; Trump DL; Mustian KM; Janelsins MC; Purnell JQ; Morrow GR
    Breast Cancer Res Treat; 2011 May; 127(1):171-7. PubMed ID: 21384167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
    Nogues X; Servitja S; Peña MJ; Prieto-Alhambra D; Nadal R; Mellibovsky L; Albanell J; Diez-Perez A; Tusquets I
    Maturitas; 2010 Jul; 66(3):291-7. PubMed ID: 20399042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation.
    Battaglia Y; Bellasi A; Bortoluzzi A; Tondolo F; Esposito P; Provenzano M; Russo D; Andreucci M; Cianciolo G; Storari A
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
    Sugimoto T; Matsumoto T; Hosoi T; Shiraki M; Kobayashi M; Okubo N; Takami H; Nakamura T
    J Bone Miner Metab; 2020 Nov; 38(6):848-858. PubMed ID: 32671481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health.
    Tan ML; Abrams SA; Osborn DA
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013046. PubMed ID: 33305822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.
    Khan QJ; Reddy PS; Kimler BF; Sharma P; Baxa SE; O'Dea AP; Klemp JR; Fabian CJ
    Breast Cancer Res Treat; 2010 Jan; 119(1):111-8. PubMed ID: 19655244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
    Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
    J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
    Geller JL; Hu B; Reed S; Mirocha J; Adams JS
    Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
    Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
    Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.
    Crew KD; Shane E; Cremers S; McMahon DJ; Irani D; Hershman DL
    J Clin Oncol; 2009 May; 27(13):2151-6. PubMed ID: 19349547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.
    Leidig-Bruckner G; Roth HJ; Bruckner T; Lorenz A; Raue F; Frank-Raue K
    Osteoporos Int; 2011 Jan; 22(1):231-40. PubMed ID: 20556359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.
    Schnabel C; Jett K; Friedman JM; Frieling I; Kruse HP; Mautner V
    Joint Bone Spine; 2013 May; 80(3):315-9. PubMed ID: 23021159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
    Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
    Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Mawatari T; Muraoka R; Iwamoto Y
    Osteoporos Int; 2017 Apr; 28(4):1279-1286. PubMed ID: 27900428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.
    Ishijima M; Sakamoto Y; Yamanaka M; Tokita A; Kitahara K; Kaneko H; Kurosawa H
    Calcif Tissue Int; 2009 Nov; 85(5):398-404. PubMed ID: 19795092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Grover I; Gunjan D; Singh N; Benjamin J; Ramakrishnan L; Pandey RM; Sati HC; Saraya A
    Am J Gastroenterol; 2021 Oct; 116(10):2098-2104. PubMed ID: 33927126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.